What Every Gastroenterologist Should Know About Achalasia Subtypes

Achalasia is an uncommon esophageal motility disorder in which inhibitory neural function at the gastroesophageal junction is impaired. The result is incomplete lower esophageal sphincter (LES) relaxation and absent or ineffective peristalsis. Patients may report progressive dysphagia to solids and liquids, regurgitation, chest discomfort, nocturnal cough, or weight loss.

Subtype classification became clinically important after high-resolution manometry (HRM) established three patterns: type I, or classic achalasia; type II, characterized by panesophageal pressurization; and type III, or spastic achalasia. These categories describe physiology rather than disease stages, and they influence treatment selection, expected response, and follow-up.

Because symptoms overlap with gastroesophageal reflux disease, peptic stricture, pseudoachalasia, and functional dysphagia, diagnosis requires more than a symptom history. A gastroenterologist must integrate endoscopy, timed barium esophagram, and HRM while considering the patient’s age, anatomy, symptom burden, and procedural risk.

Recognizing the diagnostic pattern

Endoscopy is essential to exclude mechanical obstruction, malignancy, retained food, and reflux-related injury. A dilated esophagus, salivary stasis, resistance at the EGJ, or a tightly closed LES can support suspicion, but a normal examination does not rule out achalasia.

HRM confirms the diagnosis by demonstrating impaired EGJ relaxation with absent normal peristalsis. The Chicago Classification then separates the disorder into three manometric phenotypes. If HRM findings are inconclusive, a timed barium esophagram or functional lumen imaging probe can clarify emptying and junctional distensibility.

Distinguishing the three phenotypes

Type I achalasia shows minimal pressurization and absent contractility. The esophageal body is often markedly atonic, and symptoms may reflect progressive stasis. Type II includes panesophageal pressurization in at least some swallows, indicating that the esophageal body generates pressure against a nonrelaxing outlet. This pattern generally has the most favorable response to standard therapies.

Type III is defined by premature or spastic contractions in the distal esophagus. Patients commonly experience prominent chest pain and may have less dilation than those with longstanding type I disease. The spastic segment can be long, so treatment must address more than the LES alone.

Subtype should never be interpreted in isolation. Disease duration, esophageal diameter, sigmoid deformity, retained contents, prior interventions, and the patient’s goals can change the practical meaning of a manometric result.

Matching treatment to physiology

Pneumatic dilation, laparoscopic Heller myotomy with partial fundoplication, and peroral endoscopic myotomy (POEM) are established definitive options. Type II disease often responds well to any of these approaches, while type III generally favors a tailored myotomy, frequently through POEM, because the spastic segment may extend proximally.

Botulinum toxin injection can provide temporary relief for patients who are poor candidates for definitive therapy, but repeated injections may complicate later surgical dissection. Pharmacologic smooth-muscle relaxants usually offer limited and short-lived benefit and are reserved for selected patients who cannot undergo intervention.

Before treatment, clinicians should discuss reflux risk, recurrence, need for objective follow-up, and the possibility that persistent symptoms may arise from esophageal hypersensitivity rather than obstruction. A technically successful procedure does not guarantee immediate normalization of swallowing.

Comparing clinical implications

The table below summarizes the main distinctions, while recognizing that individual patients may fall between classic patterns.

Avoiding common diagnostic errors

Pseudoachalasia deserves particular attention in older adults, patients with rapid symptom onset, or those with substantial unexplained weight loss. A short, irregular narrowing, difficult passage of the endoscope, or suspicious gastric cardia findings should prompt careful repeat evaluation and cross-sectional imaging when appropriate.

Another error is labeling persistent post-treatment dysphagia as recurrent achalasia without testing. Endoscopy can identify food retention, stricture, esophagitis, or candidiasis; timed barium studies assess emptying; and HRM or FLIP can evaluate residual EGJ obstruction. Reflux after myotomy may also mimic recurrent motility symptoms.

Educational programs devoted to esophageal disorders can help clinicians keep evolving classification systems and interventions in perspective. The ISDE 2021 archive includes registration information associated with its international congress on esophageal diseases, where scientific sessions and research presentations addressed advances in this field.

Applying subtype data in daily care

Subtype-guided counseling should begin at diagnosis and continue after intervention. Patients need practical advice about eating slowly, taking fluids with meals when useful, monitoring nocturnal regurgitation, and reporting weight loss or aspiration symptoms. Those with significant stasis may require nutritional assessment before treatment.

Follow-up should be based on symptoms plus objective findings rather than symptoms alone. A timed barium esophagram can document improvement in clearance, while endoscopy is valuable when reflux, mucosal injury, or retained food is suspected. Long-term surveillance should remain individualized because achalasia carries risks related to chronic stasis, aspiration, and, in some patients, esophageal malignancy.

Practical priorities for gastroenterologists

• Confirm impaired EGJ relaxation and absent normal peristalsis with an appropriate HRM protocol.
• Use the subtype to guide therapy, especially when evaluating a patient with type III spastic disease.
• Exclude pseudoachalasia aggressively when clinical features are atypical or rapidly progressive.
• Assess esophageal emptying and reflux after treatment instead of relying on symptom reports alone.
• Coordinate care with surgeons, advanced endoscopists, radiologists, and nutrition specialists when anatomy or prior therapy is complex.

Achalasia subtypes are most useful when they sharpen clinical judgment rather than replace it. By combining manometric pattern recognition with anatomy, disease duration, and patient priorities, gastroenterologists can select more appropriate interventions and identify treatment failure earlier. Continued attention to objective follow-up helps preserve nutrition, reduce aspiration risk, and distinguish recurrent obstruction from other causes of persistent symptoms.